HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy].

Abstract
The patient was a 32-year-old man in whom pulmonary tuberculosis had occurred 5 years after the presumptive onset of pulmonary alveolar proteinosis. A diagnosis of pulmonary tuberculosis was made by sputum smears positive for acid-fast bacilli. Computer tomography of the chest showed ground glass opacities, consolidation and cavitation. Rifampicin, isoniazid and ethambutol were given daily, and streptomycin three times a week. Serial chest radiographs revealed progressive clearing not only of the new but also of the old lung infiltrates thought to be due to pulmonary alveolar proteinosis. Serum LDH and CEA returned to normal values. This case indicates the possibility of improving pulmonary alveolar proteinosis by tuberculosis infection or antituberculosis therapy.
AuthorsYojiro Onari, Naoki Yamaoka, Masaya Taniwaki, Ryoko Nakao, Hiroshi Murai, Michikazu Terada, Toshihiko Kuraoka
JournalNihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society (Nihon Kokyuki Gakkai Zasshi) Vol. 41 Issue 6 Pg. 392-6 (Jun 2003) ISSN: 1343-3490 [Print] Japan
PMID12833844 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antitubercular Agents
  • Ethambutol
  • Isoniazid
  • Rifampin
  • Streptomycin
Topics
  • Adult
  • Antitubercular Agents (therapeutic use)
  • Drug Therapy, Combination
  • Ethambutol (administration & dosage)
  • Humans
  • Isoniazid (administration & dosage)
  • Male
  • Pulmonary Alveolar Proteinosis (pathology)
  • Remission Induction
  • Rifampin (administration & dosage)
  • Streptomycin (administration & dosage)
  • Tuberculosis, Pulmonary (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: